Literature DB >> 18037690

Pilsicainide-induced Brugada-type ECG and ventricular arrhythmias originating from the left posterior fascicle in a case with Brugada syndrome associated with idiopathic left ventricular tachycardia.

Takeshi Ueyama1, Akihiko Shimizu, Masahiro Esato, Yasuhiro Yoshiga, Akira Sawa, Shinsuke Suzuki, Naoki Sugi, Masunori Matsuzaki.   

Abstract

The patient was a 50-year-old male in 2002, who was first suspected of having a Brugada-type electrocardiogram (ECG). A drug challenge test using pilsicainide was performed and unmasked a typical coved type ST elevation followed by ventricular arrhythmias (VAs) manifesting a QRS pattern with a right bundle branch block and left axis deviation. Three years later, he was transferred to the emergency room due to a wide QRS tachycardia with the same QRS morphology as the VA that previously occurred in the drug challenge test. An ECG just after the recorded termination of the tachycardia exhibited a typical Brugada-type ECG. In an electrophysiological study, ventricular fibrillation could be easily induced with reproducibility. Since the clinical tachycardia could not be sustained by an isoproterenol infusion, mapping and catheter ablation targeting the pilsicainide-induced VAs was performed. The successful ablation site was the left mid-lower septal wall where a Purkinje potential was recorded and a false tendon was attached just to it.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18037690     DOI: 10.1093/europace/eum244

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  3 in total

1.  Catheter ablation for monomorphic ventricular tachycardia in Brugada syndrome patients: detailed characteristics and long-term follow-up.

Authors:  Sayuri Tokioka; Seiji Fukamizu; Takeshi Kitamura; Satoshi Miyazawa; Iwanari Kawamura; Rintaro Hojo; Harumizu Sakurada; Masayasu Hiraoka
Journal:  J Interv Card Electrophysiol       Date:  2019-10-12       Impact factor: 1.900

2.  Efficacy and safety of catheter ablation for Brugada syndrome: an updated systematic review.

Authors:  Yasuhito Kotake; Sumita Barua; Samia Kazi; Sohaib Virk; Ashwin Bhaskaran; Timothy Campbell; Richard G Bennett; Saurabh Kumar
Journal:  Clin Res Cardiol       Date:  2022-04-22       Impact factor: 5.460

3.  A Novel SCN5A Mutation Associated with Drug Induced Brugada Type ECG.

Authors:  Isik Turker; Takeru Makiyama; Matteo Vatta; Hideki Itoh; Takeshi Ueyama; Akihiko Shimizu; Tomohiko Ai; Minoru Horie
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.